Abstract
The present Cochrane review included 23 studies randomized placebo-controlled clinical trials with a total of 1,255 patients. The effect of autologous cell therapy versus placebo was examined on left ventricular ejection fraction (LVEF), adverse effects and mortality in patients with chronic ischaemic heart disease. Patients treated with cell therapy had improved LVEF and functional status compared to patients who received placebo. There were no cell-related and only few procedure-related side effects. A positive effect of cell therapy on long-term survival was also demonstrated.
| Translated title of the contribution | Effect of cell therapy in patients with chronic ischaemic heart disease--a survey of a Cochrane review |
|---|---|
| Original language | Danish |
| Journal | Ugeskrift for Laeger |
| Volume | 177 |
| Issue number | 7 |
| Pages (from-to) | 642-44 |
| Number of pages | 3 |
| ISSN | 0041-5782 |
| Publication status | Published - 30 Mar 2015 |
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS